Quach, David H. http://orcid.org/0000-0003-1800-9559
Becerra-Dominguez, Luis
Rouce, Rayne H.
Rooney, Cliona M.
Funding for this research was provided by:
National Institutes of Health (5T32DK60445-9)
Lymphoma Research Foundation (384827)
Leukemia and Lymphoma Society (SCOR)
Article History
Received: 14 March 2019
Accepted: 17 July 2019
First Online: 24 July 2019
Ethics approval and consent to participate
: Informed consent was obtained from all participants and approved under the Institutional Review Board of Baylor College of Medicine and in accordance with the guidelines established by the Declaration of Helsinki.
: Not Applicable.
: Baylor College of Medicine (DHQ and CMR are listed as inventors) has filed a patent application using the CHAR for cell therapy.